by IR Team | Jul 22, 2020 | News
By Verdict Medical Devices Medical Marijuana has announced that its investment company AXIM Biotechnologies has developed a rapid diagnostic test that measures the levels of functional neutralising antibodies that are said to prevent SARS-CoV-2 (Covid-19) infection....
by IR Team | Jul 21, 2020 | Press Release
SAN DIEGO, July 21, 2020 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research,...
by IR Team | Jul 16, 2020 | News
By LabMedica.com A new rapid diagnostic test for measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells could serve as an ‘Immunity Passport’ for vaccine developers around the world as they begin...
by IR Team | Jul 16, 2020 | News
By Medical Laboratory Observer AXIM Biotechnologies, an healthcare solutions company focused on oncological research, has announced the development of NeuCovix, a rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent...
by IR Team | Jul 16, 2020 | News
By HospiMedica International staff writers Posted on 16 Jul 2020 A new rapid diagnostic test for measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells could serve as an ‘Immunity Passport’ for...
